| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701497 | Journal of Thoracic Oncology | 2017 | 28 Pages |
Abstract
Postoperative radiotherapy using cRT is strongly associated with improved OS and DFS in patients with pT3N0M0 TESCC. A multicenter, randomized phase III clinical trial is warranted to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jinsong MD, Wencheng MD, Zefen MD, Qifeng MD, Zongmei MD, Hongxing MD, Dongfu MD, Qingfu MD, Jie MD, Shugeng MD, Kelin MD, Xiangyang MD, Dekang MD, Juwei MD, Dali MD, Yexiong MD,